← Back to headlines

Moderna Bets Big on mRNA Technology for Cancer Vaccines
Moderna is making a significant investment in its mRNA technology for the development of cancer vaccines. The company is focusing on this innovative approach, which Wall Street is closely watching for its potential in oncology.
24 Aug, 14:45 — 24 Aug, 14:45
Sources
Showing 1 of 2 sources
Coverage Timeline
First report: capital-bg · 24 Aug, 05:47|Full coverage: 2 · 9h|Window: 9h
Left-leaningCenterRight-leaning


